MEDX Price Prediction, Horizon Kinetics Medical ETF AI Recommendations

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Regeneron Pharmaceuticals (NASDAQ:REGN), Bristol-Myers Squibb Co (NYSE:BMY), Biogen (NASDAQ:BIIB).

The investment seeks to provide long-term growth of capital. The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.

The average market capitalization across the Horizon Kinetics Medical ETF ETF is 88.57B. The market cap for tickers in the group ranges from 2.46M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is SLRX at 2.46M.

The average weekly price growth across all stocks in the Horizon Kinetics Medical ETF ETF was -0%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was 6%. SLRX experienced the highest price growth at 10%, while BLUE experienced the biggest fall at -22%.

The average weekly volume growth across all stocks in the Horizon Kinetics Medical ETF ETF was 101%. For the same stocks of the ETF, the average monthly volume growth was 152% and the average quarterly volume growth was 94%